Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Neonates: Clinical Characteristics and Antimicrobial Therapy. [PDF]
Liu Z +6 more
europepmc +1 more source
Antimicrobial Activity of Aztreonam-Avibactam and Other β-Lactamase Inhibitor Combinations Tested Against Enterobacterales Isolates from Pediatric Patients from United States Medical Centers (2019-2023). [PDF]
Sader HS +4 more
europepmc +1 more source
Correction: Molecular resistance mechanisms to newly approved antibiotics (2017-2025) in WHO priority pathogens. [PDF]
Frontiers Production Office.
europepmc +1 more source
Antimicrobial susceptibility of Enterobacterales causing infection in the elderly: focus on aztreonam-avibactam and recently approved β-lactamase inhibitor combinations. [PDF]
Sader HS +5 more
europepmc +1 more source
Influence of PER-7 on cefiderocol susceptibility in clinical isolates of <i>Acinetobacter baumannii</i> producing OXA-23 or OXA-72 carbapenemases. [PDF]
Turowski P +4 more
europepmc +1 more source
Antimicrobial Susceptibility of Ceftazidime-Avibactam in Clinical Isolates of Carbapenemase-Producing Enterobacterales. [PDF]
Jain S, Vyas A, Chaturvedi P.
europepmc +1 more source
Antibiotics for the Treatment of Patients with Metallo-β-Lactamase (MBL)-Producing Gram-Negative Bacterial Infections. [PDF]
Falagas ME +3 more
europepmc +1 more source

